Pain control in bone marrow aspiration and biopsy
Phase 2
Recruiting
- Conditions
- Bone marrow disease.Multiple myeloma and malignant plasma cell neoplasms
- Registration Number
- IRCT20200427047215N2
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Age 18-55 years
Conscious consent to enter the study
BMI 18-25
Exclusion Criteria
Mental retardation
Generalized anxiety disorder
Major Depressive Disorder
Pregnancy
Lactation
Drug addiction
Take analgesic less than 4 hours before admission
Hypersensitivity to apotel, promethazine and lidocaine
GFR < 30
Cirrhosis Child B & C
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of pain during bone marrow biopsy and aspiration. Timepoint: Immediately after completing the procedure and 30 minutes later in the intervention and control groups. Method of measurement: To estimate the severity of pain and the effect of the drug in relieving the patient's pain from the quantitative scale VAS(Visual Analog Scale) is used.;Anxiety after completing the procedure. Timepoint: After the procedure and 30 minutes later, the patient's anxiety is rated from 1 to 10, depending on the severity. Method of measurement: Anxiety severity is divided from zero to ten using a questionnaire.
- Secondary Outcome Measures
Name Time Method